Updated applications of Ultrasound in Uterine Cervical Cancer
- PMID: 33758596
- PMCID: PMC7974902
- DOI: 10.7150/jca.49479
Updated applications of Ultrasound in Uterine Cervical Cancer
Abstract
Cervical cancer is a common gynecologic malignancy worldwide. It is the fourth for both incidence and mortality. For cervical cancer, imaging and pathology assessments are incorporated in the revised 2018 Federation of Gynecology and Obstetrics (FIGO) staging system. Uses of imaging techniques for the pre-treatment work-up of cervical cancer have been increasing. Among imaging techniques for the evaluation of cervical cancer, ultrasound is cheaper, faster and widely available than other imaging techniques such as computed tomography (CT) or magnetic resonance imaging (MRI). Advanced technique in ultrasound, such as three-dimension (3D) ultrasound and color Doppler, have improved the clinical application of ultrasound in cervical cancer. Ultrasound may provide highly accurate information on detecting tumor presence and evaluating local tumor extent if performed by ultrasound-trained gynecologists; the experience of readers is also critical for correct pretreatment staging and assessment of response to treatment. Sonographic images could be useful to predict response of neoadjuvant chemotherapy, radiotherapy, chemotherapy and concurrent chemoradiotherapy in patients with cervical cancer. This review article attempted to present the most updated specific applications of ultrasound in cervical cancer.
Keywords: cervical cancer; staging; therapy; ultrasound.
© The author(s).
Conflict of interest statement
Competing Interests: The authors have declared that no competing interest exists.
Figures



Similar articles
-
The role of ultrasound in primary workup of cervical cancer staging (ESGO, ESTRO, ESP cervical cancer guidelines).Ceska Gynekol. 2019 Winter;84(1):40-48. Ceska Gynekol. 2019. PMID: 31213057 Review. English.
-
Revised FIGO Staging for Cervical Cancer - A New Role for MRI.Rofo. 2020 Oct;192(10):937-944. doi: 10.1055/a-1198-5729. Epub 2020 Jul 30. Rofo. 2020. PMID: 32731266 Review. English, German.
-
Evaluation of Parametrial Status in Locally Advanced Cervical Cancer Patients after Neoadjuvant Chemotherapy: A Prospective Study on Diagnostic Accuracy of Three-Dimensional Transvaginal Ultrasound.Oncology. 2020;98(9):603-611. doi: 10.1159/000506642. Epub 2020 Jun 3. Oncology. 2020. PMID: 32492692
-
Role of imaging in pretreatment evaluation of early invasive cervical cancer: results of the intergroup study American College of Radiology Imaging Network 6651-Gynecologic Oncology Group 183.J Clin Oncol. 2005 Dec 20;23(36):9329-37. doi: 10.1200/JCO.2005.02.0354. J Clin Oncol. 2005. PMID: 16361632 Clinical Trial.
-
PRospective Imaging of CErvical cancer and neoadjuvant treatment (PRICE) study: role of ultrasound to assess residual tumor in locally advanced cervical cancer patients undergoing chemoradiation and radical surgery.Ultrasound Obstet Gynecol. 2018 Jul;52(1):110-118. doi: 10.1002/uog.18953. Ultrasound Obstet Gynecol. 2018. PMID: 29119649
Cited by
-
Recent Imaging Updates and Advances in Gynecologic Malignancies.Cancers (Basel). 2022 Nov 10;14(22):5528. doi: 10.3390/cancers14225528. Cancers (Basel). 2022. PMID: 36428624 Free PMC article. Review.
-
Utility of 3T MRI in Women with IB1 Cervical Cancer in Determining the Necessity of Less Invasive Surgery.Cancers (Basel). 2022 Jan 4;14(1):224. doi: 10.3390/cancers14010224. Cancers (Basel). 2022. PMID: 35008388 Free PMC article.
-
Development and Validation of the Promising PPAR Signaling Pathway-Based Prognostic Prediction Model in Uterine Cervical Cancer.PPAR Res. 2023 May 31;2023:4962460. doi: 10.1155/2023/4962460. eCollection 2023. PPAR Res. 2023. PMID: 37292383 Free PMC article.
-
VEGFR2 targeted microbubble-based ultrasound molecular imaging improving the diagnostic sensitivity of microinvasive cervical cancer.J Nanobiotechnology. 2023 Jul 12;21(1):220. doi: 10.1186/s12951-023-01984-2. J Nanobiotechnology. 2023. PMID: 37438780 Free PMC article.
-
Integration of Ultrasound in Image-Guided Adaptive Brachytherapy in Cancer of the Uterine Cervix.Bioengineering (Basel). 2024 May 17;11(5):506. doi: 10.3390/bioengineering11050506. Bioengineering (Basel). 2024. PMID: 38790373 Free PMC article. Review.
References
-
- Bray F, Ferlay J, Soerjomataram I. et al. Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. - PubMed
-
- Small W Jr, Bacon MA, Bajaj A. et al. Cervical cancer: A global health crisis. Cancer. 2017;123:2404–12. - PubMed
-
- Crosbie EJ, Einstein MH, Franceschi S. et al. Human papillomavirus and cervical cancer. Lancet. 2013;382:889–99. - PubMed
-
- Cohen PA, Jhingran A, Oaknin A. et al. Cervical cancer. Lancet. 2019;393:169–82. - PubMed
-
- Stehman FB, Bundy BN, DiSaia PJ. et al. Carcinoma of the cervix treated with radiation therapy. I. A multi-variate analysis of prognostic variables in the Gynecologic Oncology Group. Cancer. 1991;67:2776–85. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources